Loading...
Market
When will University of Houston's fentanyl vaccine show positive results in Phase 1 clinical trials?
2
Resolution / Starting Odds
Q3 2025 (Jul-Sep) • 25%
Q4 2025 (Oct-Dec) • 25%
Not by end of 2025 • 25%
Not at all • 25%
Official announcement from University of Houston or clinical trial registry
Story
University of Houston's Fentanyl Vaccine to Enter Clinical Trials
Sep 2, 2024, 11:28 AM
Researchers at the University of Houston have developed a fentanyl vaccine that is set to enter clinical trials by mid-next year. The vaccine has shown success in animal studies and is designed to prevent the highly addictive opioid from entering the brain, thereby reducing the risk of overdose. This initiative aims to provide a groundbreaking solution to the ongoing opioid crisis.
View original story
Similar markets
Phase 1 • 25%
Phase 2 • 25%
Phase 3 • 25%
No trial • 25%
Yes • 50%
No • 50%
United States • 25%
Europe • 25%
Asia • 25%
Other • 25%
Positive • 25%
Negative • 25%
Mixed • 25%
Not published • 25%
Yes • 50%
No • 50%
Successful • 25%
Partially successful • 25%
Unsuccessful • 25%
No results announced • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
RSV • 33%
hMPV • 33%
Other • 34%